Child & Adolescent: Conference Sessions

MGH 50th Annual Psychopharmacology Conference

October 16–18, 2026 · Boston, MA

• LectureIs Adolescent Cannabis Use a Causal Factor for Schizophrenia?

  Eden Evins

  Examines the evidence on whether cannabis use during adolescence contributes causally to schizophrenia.

  Cannabis & CannabinoidsSchizophrenia & Psychosis

• LectureRisks and Harms: Evidence in Adolescents

  Randi Schuster

  Reviews evidence on the risks and harms of cannabis use in adolescents.

  Cannabis & Cannabinoids

• SessionIlluminating the Black Box: Antidepressants, Youth, and Suicide

  Khadijah Watkins

  Evening seminar re-examining the evidence behind the antidepressant black-box warning in young people.

  DepressionDrug Interactions & SafetySuicide & Self-Harm

• LecturePediatric Bipolar Disorder and Mood Disorders

  Mai Uchida

  Diagnosis and treatment of bipolar and other mood disorders in children and adolescents.

  Bipolar DisorderDepression

AACAP Annual Meeting 2026

October 26–31, 2026 · Atlanta, GA

• CourseAdvances in Characterization and Therapeutics of Autism

  Gagan Joshi · Natasha Marrus · Amandeep Jutla · Aaron D. Besterman · Kathleen A. Koth · Roma Vasa · James Luccarelli

  Full-day institute giving clinicians an evidence-based update on autism assessment and management — current prevalence data, psychiatric comorbidity treatment, and emerging interventions — with emphasis on individualized multimodal treatment planning.

  Autism & Neurodevelopmental Disorders

• CourseUnderstanding and Managing Language Deficits in Pediatric Clinical Populations: Updates and Advances

  Theodore A. Petti · Stacy S. Drury · Mayank Gupta · Anthony Joseph Deo · Jennifer Zuk · Tyler Whitney · Gabrielle Blackman

  Institute on the frequently missed problem of language deficits in children with emotional, behavioral, and psychotic disorders, covering screening, neurobiology, comorbidity with ASD/ADHD, and referral for special education services.

  ADHDAutism & Neurodevelopmental Disorders

• SymposiumBefore the Diagnosis: Early Signals of Emerging ADHD

  Heather Marie Joseph · Sarah Karalunas · Marissa M. Dennis · Alexis Federico · Anastasia N. Kerr-German · Madelyn Heise

  Research symposium on prodromal markers of ADHD in early childhood, before formal diagnosis, drawing on developmental and neurocognitive cohort work.

  ADHD

• SymposiumStuck at the Crossroads: Management of Treatment-Resistant Schizophrenia in Youth

  Henry Teaford · Brent Beck · Tatum Burdo · Shruti Tilak

  Clinical perspectives session on managing treatment-resistant schizophrenia in children and adolescents, including when and how to move to clozapine and other next-step strategies.

  ClozapineSchizophrenia & Psychosis

• SymposiumFrom Evidence to Practice: 2026 Update on Pharmacogenetic Guidance for the Child and Adolescent Psychiatric Provider

  Lisa B. Namerow · Salma Malik · Jeffrey Robert Strawn · Laura B. Ramsey · Jeffrey R. Bishop

  Annual update on pharmacogenetic testing guidance for pediatric psychiatric prescribing, from clinician-researchers including Jeffrey Strawn, Laura Ramsey, and Jeffrey Bishop.

  Pharmacogenomics & Precision Psychiatry

See all 1361 child & adolescent sessions at this meeting →

APNA 40th Annual Conference

October 28–31, 2026 · Phoenix, AZ

• WorkshopThe Role of the Psychiatric-Mental Health Advanced Practice Nurse in Diagnosing Autism Spectrum Disorder

  Renee Nauful

  Explores PMH-APRN scope in autism diagnosis, covering assessment instruments and differential diagnosis approaches.

  Autism & Neurodevelopmental DisordersMeasurement-Based Care & Diagnosis

• CourseChild & Adolescent Psychiatric Nursing Boot Camp – Part 1

  Jamie Zelazny · Jessica M. Gordon · Isabel Grace Buckingham · Michaela K. Hogan

  First half of a two-part intensive covering developmental foundations, psychiatric assessment, safety evaluation, and crisis management in youth.

  Emergency & Acute PsychiatryMeasurement-Based Care & Diagnosis

• WorkshopNeuroplasticity in Substance Use Care: From Brain Development and Environmental Drivers to Integrated Treatment and Provider Resilience

  Laura Leahy · Susan Caverly · Lee Moore

  Connects neuroplasticity science and environmental determinants to youth substance use, recovery pathways, and clinician resilience.

  Neuroscience & MechanismsSubstance Use Disorders

• WorkshopRebuilding Safety Culture: Transforming Injury Reduction and BPPE Practices on a Neurobehavioral Unit

  Austin Corsmeier

  Multi-year safety overhaul of a pediatric neurobehavioral unit that cut staff injuries and restraint use.

  Emergency & Acute PsychiatryPractice, Policy & Workforce

• CourseChild & Adolescent Psychiatric Nursing Boot Camp – Part 2

  Jessica M. Gordon · Jamie Zelazny · Isabel Grace Buckingham · Michaela K. Hogan · Tracee Ridley-Pryor

  Second half of the youth psychiatry intensive, focused on evidence-based treatment, medication decision-making, and combined therapy approaches.

  Psychotherapy

See all 8 child & adolescent sessions at this meeting →

NEI Fall Congress 2026

November 5–8, 2026 · Colorado Springs, CO

• SymposiumYou Need to Calm Down: Addressing Irritability and Emotional Dysregulation in Youth With Autism Spectrum Disorder

  Adelaide S. Robb

  Approaches to managing irritability and emotional dysregulation in children and adolescents with autism spectrum disorder.

  Autism & Neurodevelopmental Disorders

• SymposiumShould I Stay or Should I Go? Using Dopamine Receptor Blocking Agents in Pediatrics

  Jeffrey Robert Strawn

  Weighs when to start, continue, or stop dopamine receptor blocking agents in pediatric patients, including safety and monitoring considerations.

  Antipsychotic PrescribingDrug Interactions & Safety

• SymposiumUnder Pressure: Addressing Picky, Restricted, or Disordered Eating in Children and Adolescents

  Katherine K. Dahlsgaard

  Clinical strategies for evaluating and treating picky, restrictive, and disordered eating patterns in youth.

  Eating Disorders

• SymposiumDon't You Worry Child: Practical and Evidence-Based Care of Pediatric Anxiety

  Jeffrey Robert Strawn · Katherine K. Dahlsgaard

  Recognition, assessment, and evidence-based pharmacologic and psychotherapeutic management of anxiety disorders in children and adolescents.

  Anxiety Disorders

• SymposiumI Still Haven't Found What I'm Looking For: Practical ADHD Management in Complex Cases

  Timothy E. Wilens

  Managing ADHD complicated by executive dysfunction and psychiatric comorbidity, with practical treatment-optimization tactics.

  ADHD

AAAP 37th Annual Meeting and Scientific Symposium

November 12–15, 2026 · Memphis, TN

• WorkshopAges 11–17: Understanding the Social Drivers of Early Substance Use Through Interactive Cases

  Philipa Owusu-Antwi · Sandra Gomez-Luna · Adina Bowe

  Interactive case discussions on the social and environmental drivers of substance use initiation in early adolescence.

  Substance Use Disorders

• WorkshopAnyone Can Treat! Building Confidence in Treating Youth Cannabis Use Disorder

  Gerald Busch · Ravi Shankar · Cathryn A. Galanter

  Builds general clinicians' confidence and skills in treating cannabis use disorder in adolescents.

  Cannabis & CannabinoidsSubstance Use Disorders

• WorkshopWhat Are You Smoking?: Addressing Nicotine and Cannabis Use in Adolescents

  Jennifer Creedon · Britney Lambert · Kimberly Rousseau

  Assessment and treatment strategies for nicotine and cannabis use among adolescents.

  Cannabis & CannabinoidsSubstance Use Disorders

• Oral abstractShort-Term Clinical Outcomes in Early Psychosis with and without Recent Substance Use: The Role of Urine Drug Screening and Antipsychotics in an Urban Youth Cohort

  Chaden Noureddine

  Looks at short-term outcomes in youth with early psychosis by recent substance use, urine drug screening and antipsychotic use.

  Schizophrenia & PsychosisSubstance Use Disorders

• Oral abstractSubstance Use and Outcomes following Intramuscular Antipsychotic Treatment for Acute Pediatric Agitation: A Retrospective Cohort Study

  Angelo Chaia

  Retrospective study of outcomes after intramuscular antipsychotics for pediatric agitation, by substance use status.

  Antipsychotic PrescribingEmergency & Acute PsychiatrySubstance Use Disorders

See all 14 child & adolescent sessions at this meeting →

NPA 32nd Annual Psychopharmacology Update 2027

February 10–13, 2027 · Las Vegas, NV

• LectureTreatment of Anxiety in Children and Adolescents

  Jeffrey Robert Strawn

  Evidence-based pharmacologic and psychotherapeutic treatment of pediatric anxiety disorders.

  Anxiety Disorders

• LectureTreatment of Mood Disorders in Children and Adolescents

  Manpreet K. Singh

  Current approaches to treating depression and bipolar disorder in youth.

  Bipolar DisorderDepression

• LectureSuicide Prevention in Youth

  Shashank V. Joshi

  Risk assessment and prevention strategies for suicidality in children and adolescents.

  Suicide & Self-Harm

Substance Use Disorders: A Comprehensive Review and Update 2027

February 15–17, 2027 · Lake Buena Vista, FL

• LectureAdolescent Substance Use Disorders

  Robert R. Althoff

  Overview of substance use disorders in adolescents.

  Substance Use Disorders

• PanelPanel Discussion

  Timothy E. Wilens · Robert R. Althoff

  Panel discussion on adolescent substance use topics.

  Substance Use Disorders

MasterPsych Child & Adolescent Psychiatry Conference 2027

April 12–15, 2027 · San Diego, CA

• LectureLecture Series

  A lecture series on child and adolescent psychopharmacology spanning ADHD and mood disorders, anxiety/OCD/trauma, psychosis and substance use, difficult cases, wellness, and non-pharmacologic topics such as suicide risk and AI.

  Education & Training

39th ECNP Congress

October 10–13, 2026 · Munich, Germany

• LectureE03 – Advances in Tourette syndrome research

  Tammy Hedderly · Juan Carlos Baldermann

  Update on childhood diagnosis and the neuropathophysiology and treatment of Tourette syndrome.

  Autism & Neurodevelopmental DisordersNeuroscience & Mechanisms

• SymposiumS11 – The impact of early-life stress on brain development and psychopathology

  Juan Pablo Lopez · Thorhildur Halldorsdottir · Donghao Lu

  Animal and cohort evidence on how early adversity and prenatal factors shape brain development and later psychopathology.

  Neuroscience & MechanismsPTSD & Trauma

• CourseCS02 – ECNP Child & Adolescent Psychiatry Course Session – from evidence-based care to precision approaches

  Hilgo Bruining · Gonzalo Salazar de Pablo

  Interactive course on evidence-based and precision approaches to child and adolescent psychiatry and neurodevelopmental disorders.

  Autism & Neurodevelopmental DisordersPharmacogenomics & Precision Psychiatry

• PlenaryPL06 – Virtual reality in youth mental health: evidence, applications and future directions

  Lucia Valmaggia

  Plenary reviewing the evidence for VR-based assessment and treatment in youth mental health.

  Digital Psychiatry & AI

• LectureE07 – Long-term effects of ADHD medication: new evidence from real-world data

  Guido Biele · Kenneth Man

  Real-world evidence on long-term academic outcomes and the safety of methylphenidate in children.

  ADHDStimulants & ADHD Medications

WCP 2026 — 26th World Congress of Psychiatry

September 23–26, 2026 · Stockholm, Sweden

• SessionPresidential Panel: Online Spaces in Youth Suicide Prevention – Therapeutic Promise and Digital Dangers

  Panel weighing digital platforms as both a suicide-prevention tool and a risk environment for young people.

  Digital Psychiatry & AISuicide & Self-Harm

• LectureDistinguished Lectures: Youth in Crisis: Social Withdrawal, Global Contexts, and Psychiatric Education

  Education & Training

Medical Psychiatry: Comprehensive Update Conference 2026

September 17–20, 2026 · Online

• LectureManagement of Behavioral Outbursts in Developmentally Delayed Children, Adolescents, and Young Adults in the Hospital Setting

  Usman Ghumman

  Strategies for managing behavioral crises in hospitalized patients with developmental disabilities across the pediatric-to-young-adult span.

  Autism & Neurodevelopmental DisordersEmergency & Acute Psychiatry

Psych Congress 2026

September 15–19, 2026 · New Orleans, LA

• SymposiumRethinking Pediatric Depression: Early Identification and Emerging Treatments

  Adelaide S. Robb · Julie Carbray · Liv Lewis

  Reviews atypical presentations of youth depression and newer options including rapid-acting agents and digital therapeutics, with strategies for early detection in schools and primary care and a lived-experience perspective.

  DepressionDigital Psychiatry & AI

• SymposiumPractical Management of Autism and Co-Occurring Psychiatric Conditions

  Kristin Sohl · Jo Hughes

  Integrated framework for assessing and treating anxiety, ADHD, and mood disorders in autistic children, including evidence-based medication use, behavioral therapy, and family engagement.

  ADHDAnxiety DisordersAutism & Neurodevelopmental Disorders